November 16, 2021
Via: The Wall Street JournalPfizer Inc. is licensing its experimental Covid-19 antiviral to a global health organization in an effort to make the pill more readily available to people in low- and middle-income countries. Under the licensing agreement, the United Nations-backed Medicines Patent Pool […]
April 23, 2024
April 11, 2024
March 28, 2024
April 8, 2024
April 8, 2024
March 27, 2024